Thomas S Mchugh - Net Worth and Insider Trading
Thomas S Mchugh Net Worth
The estimated net worth of Thomas S Mchugh is at least $912,681 dollars as of 2024-12-26. Thomas S Mchugh is the CFO of Avadel Pharmaceuticals PLC and owns about 87,800 shares of Avadel Pharmaceuticals PLC (AVDL) stock worth over $912,681. Details can be seen in Thomas S Mchugh's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas S Mchugh has not made any transactions after 2024-12-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Thomas S Mchugh
Thomas S Mchugh Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas S Mchugh owns 2 companies in total, including Avadel Pharmaceuticals PLC (AVDL) , and Huttig Building Products Inc (HBP) .
Click here to see the complete history of Thomas S Mchugh’s form 4 insider trades.
Insider Ownership Summary of Thomas S Mchugh
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVDL | Avadel Pharmaceuticals PLC | 2024-12-13 | Chief Financial Officer |
| HBP | Huttig Building Products Inc | 2003-09-15 | Vice President of Finance&CFO |
Thomas S Mchugh Latest Holdings Summary
Thomas S Mchugh currently owns a total of 1 stock. Thomas S Mchugh owns 87,800 shares of Avadel Pharmaceuticals PLC (AVDL) as of December 13, 2024, with a value of $912,681.
Latest Holdings of Thomas S Mchugh
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AVDL | Avadel Pharmaceuticals PLC | 2024-12-13 | 87,800 | 10.40 | 912,681 |
Holding Weightings of Thomas S Mchugh
Thomas S Mchugh Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas S Mchugh has made a total of 9 transactions in Avadel Pharmaceuticals PLC (AVDL) over the past 5 years, including 9 buys and 0 sells. The most-recent trade in Avadel Pharmaceuticals PLC is the acquisition of 2,300 shares on December 13, 2024, which cost Thomas S Mchugh around $24,012.
Insider Trading History of Thomas S Mchugh
- 1
Thomas S Mchugh Trading Performance
GuruFocus tracks the stock performance after each of Thomas S Mchugh's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas S Mchugh is 29.33%. GuruFocus also compares Thomas S Mchugh's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas S Mchugh within 3 months outperforms 5 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Thomas S Mchugh's insider trading performs compared to the benchmark.
Performance of Thomas S Mchugh
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -14.39 | | | | | |
| Relative Return to S&P 500(%) | -13.81 | | | | | |
Thomas S Mchugh Ownership Network
Thomas S Mchugh Owned Company Details
What does Avadel Pharmaceuticals PLC do?
Who are the key executives at Avadel Pharmaceuticals PLC?
Thomas S Mchugh is the Chief Financial Officer of Avadel Pharmaceuticals PLC. Other key executives at Avadel Pharmaceuticals PLC include director & Chief Executive Officer Greg J Divis , Chief Commercial Officer Richard J Kim , and Chief Medical Officer Douglas J Williamson .
Avadel Pharmaceuticals PLC (AVDL) Insider Trades Summary
Over the past 18 months, Thomas S Mchugh made 4 insider transaction in Avadel Pharmaceuticals PLC (AVDL) with a net purchase of 11,300. Other recent insider transactions involving Avadel Pharmaceuticals PLC (AVDL) include a net sale of 103,975 shares made by Mark Anthony Mccamish , a net purchase of 34,279 shares made by Geoffrey Michael Glass , and a net purchase of 20,000 shares made by Greg J Divis .
In summary, during the past 3 months, insiders sold 0 shares of Avadel Pharmaceuticals PLC (AVDL) in total and bought 40,579 shares, with a net purchase of 40,579 shares. During the past 18 months, 103,975 shares of Avadel Pharmaceuticals PLC (AVDL) were sold and 68,579 shares were bought by its insiders, resulting in a net sale of 35,396 shares.
Avadel Pharmaceuticals PLC (AVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avadel Pharmaceuticals PLC Insider Transactions
Thomas S Mchugh Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas S Mchugh. You might contact Thomas S Mchugh via mailing address: 2280 Schuetz Road, St. Louis Mo 63146.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
